Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria
We report the first in vitro and genetic confirmation of Malarone(®) (GlaxoSmithKline; atovaquone and proguanil hydrochloride) resistance in Plasmodium falciparum acquired in Africa. On presenting with malaria two weeks after returning from a 4-week visit to Lagos, Nigeria without prophylaxis, a mal...
Kaydedildi:
| Yayımlandı: | Malar J |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2002
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC111499/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12057021/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1475-2875-1-1 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|